Article info
PDFA difficult case
Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
- Correspondence to Dr Ali Kirresh, Department of Neurology, Imperial College NHS Trust, St Mary's Hospital, London W2 1NY, UK; ali.kirresh{at}doctors.org.uk
Citation
Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
Publication history
- Accepted February 22, 2016
- First published March 10, 2016.
Online issue publication
July 14, 2016
Article Versions
- Previous version (10 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome
- Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
- Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
- “Periodic fever” without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis
- Recurrent fevers in children: TRAPS for young players
- Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features
- Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome
- The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
- Recommendations for the management of autoinflammatory diseases
- A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients